Delphine Bredel
Inserm(FR)Institut Gustave Roussy(FR)
Publications by Year
Research Areas
Occupational and environmental lung diseases, Pleural and Pulmonary Diseases, Medical Imaging and Pathology Studies, Cancer Immunotherapy and Biomarkers, Pancreatic and Hepatic Oncology Research
Most-Cited Works
- → Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19(2020)906 cited
- → Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers(2021)165 cited
- → Immunodynamics of explanted human tumors for immuno‐oncology(2020)37 cited
- → Safety, recommended dose, efficacy and immune correlates for nintedanib in combination with pembrolizumab in patients with advanced cancers(2022)27 cited
- → Genomic Instability and Protumoral Inflammation Are Associated with Primary Resistance to Anti–PD-1 + Antiangiogenesis in Malignant Pleural Mesothelioma(2023)25 cited
- → Immune checkpoints are predominantly co-expressed by clonally expanded CD4+FoxP3+ intratumoral T-cells in primary human cancers(2023)9 cited
- → New α- and SIN γ-retrovectors for safe transduction and specific transgene expression in pancreatic β cell lines(2019)5 cited
- → Increased IFN responses drive myeloid cell activation in people living with HIV-1(2025)1 cited
- → 378 Efficacy, safety and ancillary analyses of pembrolizumab in combination with nintedanib for the treatment of patients with relapsed advanced mesothelioma(2021)1 cited
- → 1732MO Pembrolizumab and nintedanib for patients with advanced mesothelioma(2021)1 cited